These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2767014)

  • 21. Electrophysiologic effects of gamma-vinyl GABA and carbamazepine.
    Mervaala E; Partanen J; Nousianinen U; Sivenius J; Riekkinen P
    Epilepsia; 1989; 30(2):189-93. PubMed ID: 2924744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of tolerance to the effects of vigabatrin (gamma-vinyl-GABA) on GABA release from rat cerebral cortex, spinal cord and retina.
    Neal MJ; Shah MA
    Br J Pharmacol; 1990 Jun; 100(2):324-8. PubMed ID: 2379037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of tolerance to the anticonvulsant effect of vigabatrin in amygdala-kindled rats.
    Rundfeldt C; Löscher W
    Eur J Pharmacol; 1992 Mar; 213(3):351-66. PubMed ID: 1618278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunocytochemical evidence that vigabatrin in rats causes GABA accumulation in glial cells of the retina.
    Neal MJ; Cunningham JR; Shah MA; Yazulla S
    Neurosci Lett; 1989 Mar; 98(1):29-32. PubMed ID: 2710396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of gamma-vinyl-GABA on the human electroencephalogram.
    Hammond EJ; Wilder BJ
    Neuropharmacology; 1985 Oct; 24(10):975-84. PubMed ID: 2999635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of gamma-vinyl GABA on bicuculline-induced seizures.
    Kendall DA; Fox DA; Enna SJ
    Neuropharmacology; 1981 Apr; 20(4):351-5. PubMed ID: 7290349
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of vigabatrin on brain and platelet GABA-transaminase activities.
    Bolton JB; Rimmer E; Williams J; Richens A
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):35S-42S. PubMed ID: 2757907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vigabatrin (gamma-vinyl-GABA): neuropathologic evaluation in five patients.
    Sivenius J; Paljärvi L; Vapalahti M; Nousiainen U; Riekkinen PJ
    Epilepsia; 1993; 34(1):193-6. PubMed ID: 8422859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of substantia nigra gamma-vinyl-GABA infusions on flurothyl seizures in adult rats.
    Xu SG; Garant DS; Sperber EF; Moshé SL
    Brain Res; 1991 Dec; 566(1-2):108-14. PubMed ID: 1814529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-seizure and anti-epileptogenic effect of gamma-vinyl gamma-aminobutyric acid in amygdaloid kindling.
    Shin C; Rigsbee LC; McNamara JO
    Brain Res; 1986 Nov; 398(2):370-4. PubMed ID: 3026570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of gamma-vinyl GABA (vigabatrin) on blood pressure and body weight of hypertensive and normotensive rats.
    Singewald N; Pfitscher A; Philippu A
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):181-6. PubMed ID: 1570022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model.
    Löscher W; Jäckel R; Müller F
    Eur J Pharmacol; 1989 Apr; 163(1):1-14. PubMed ID: 2744084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacology of vigabatrin.
    Schechter PJ
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):19S-22S. PubMed ID: 2667604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of vigabatrin on evoked potentials in epileptic patients.
    Cosi V; Callieco R; Galimberti CA; Manni R; Tartara A; Mumford J; Perucca E
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):61S-68S. PubMed ID: 2757911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity of vigabatrin for the GABAergic system in human epilepsy.
    Riekkinen PJ; Pitkanen A; Ylinen A; Sivenius J; Halonen T
    Epilepsia; 1989; 30 Suppl 3():S18-22. PubMed ID: 2767015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotoxicologic concerns with vigabatrin.
    Lhoir A
    Acta Clin Belg; 1992; 47(5):351-2. PubMed ID: 1334323
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental studies of the influence of vigabatrin on the GABA system.
    Gram L; Larsson OM; Johnsen A; Schousboe A
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):13S-17S. PubMed ID: 2757904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vigabatrin in epilepsy in mentally retarded patients.
    Matilainen R; Pitkänen A; Ruutiainen T; Mervaala E; Riekkinen P
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):113S-118S. PubMed ID: 2757902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in CSF and brain soluble proteins following vigabatrin treatment in rats.
    Persson LI; Rönnbäck L; Ben-Menachem E; Eriksson P; Nilsson M
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):73S-77S. PubMed ID: 2757913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of a GABA transaminase inhibitor, gamma-vinyl GABA, on voluntary morphine consumption in the rat.
    Buckett WR
    Psychopharmacology (Berl); 1981; 75(2):214-6. PubMed ID: 6798609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.